Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 31.60
-1.00 (-3.07%)
May 29, 2026, 1:54 PM CST
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.27 billion as of May 29, 2026. Its market cap has decreased by -36.11% in one year.
Market Cap
1.27B
Enterprise Value
1.26B
Revenue
501.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.60
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.27B, a decrease of -24.33%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.27B | -49.21% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OK Biotech | 2.10B |
| Dynamic Medical Technologies | 2.02B |
| Taiwan Biomaterial | 1.61B |
| Bioptik Technology Incorporation | 1.37B |
| NaviFUS | 1.25B |
| Cowealth Medical Holding | 1.20B |
| AViTA | 1.19B |
| Rossmax International | 1.17B |